Prolastin-C is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare genetic condition. Prolastin-C is also known by its drug name, alpha1-proteinase inhibitor [human].
Prolastin-C is an alpha1-proteinase inhibitor, a type of molecule derived from human plasma. Prolastin-C is believed to work by protecting the lungs from damage.
How do I take it?
Prolastin-C is administered once a week as an intravenous infusion.
Prolastin-C comes in vial form and requires reconstitution.
The FDA-approved label for Prolastin-C lists common side effects including upper respiratory tract infections.
Rare but serious side effects listed for Prolastin-C can include the potential risk for transmitting infectious agents such as viruses.